Evidence map›Paper›PMID 36862756›Full record

ArticlePloS one2023

Community exposures among Colorado adults who tested positive for SARS-CoV-2 -A case-control study, March-December 2021.

Alice E White, Amanda D Tran, Michelle R Torok, Rachel H Jervis, Bernadette A Albanese, Andrea G Buchwald, Emma Schmoll, Ginger Stringer, Rachel K Herlihy, Elaine J Scallan Walter

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Alice E WhiteDepartment of Epidemiology, Colorado School of Public Health, Aurora, Colorado, United States of America.ORCID 0000-0001-5496-708X
Amanda D TranDepartment of Epidemiology, Colorado School of Public Health, Aurora, Colorado, United States of America.
Michelle R TorokDepartment of Epidemiology, Colorado School of Public Health, Aurora, Colorado, United States of America.
Rachel H JervisCommunicable Disease Branch Division of Disease Control and Public Health Response, Colorado Department of Public Health and Environment, Denver, Colorado, United States of America.
Bernadette A AlbaneseTri-County Health Department, Greenwood Village, Colorado, United States of America.
Andrea G BuchwaldCenter for Innovative Design and Analysis, Colorado School of Public Health, Aurora, Colorado, United States of America.
Emma SchmollCommunicable Disease Branch Division of Disease Control and Public Health Response, Colorado Department of Public Health and Environment, Denver, Colorado, United States of America.
Ginger StringerCommunicable Disease Branch Division of Disease Control and Public Health Response, Colorado Department of Public Health and Environment, Denver, Colorado, United States of America.
Rachel K HerlihyCommunicable Disease Branch Division of Disease Control and Public Health Response, Colorado Department of Public Health and Environment, Denver, Colorado, United States of America.
Elaine J Scallan WalterDepartment of Epidemiology, Colorado School of Public Health, Aurora, Colorado, United States of America.
Colorado School of Public Health · USColorado Department of Public Health and Environment · USTri-County Health Department · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes coronavirus disease 2019 (COVID-19), is spread primarily through exposure to respiratory droplets from close contact with an infected person. To inform prevention measures, we conducted a case-control study among Colorado adults to assess the risk of SARS-CoV-2 infection from community exposures.

methodsCases were symptomatic Colorado adults (aged ≥18 years) with a positive SARS-CoV-2 test by reverse transcription-polymerase chain reaction (RT-PCR) reported to Colorado's COVID-19 surveillance system. From March 16 to December 23, 2021, cases were randomly selected from surveillance data ≤12 days after their specimen collection date. Cases were matched on age, zip code (urban areas) or region (rural/frontier areas), and specimen collection date with controls randomly selected among persons with a reported negative SARS-CoV-2 test result. Data on close contact and community exposures were obtained from surveillance and a survey administered online.

resultsThe most common exposure locations among all cases and controls were place of employment, social events, or gatherings and the most frequently reported exposure relationship was co-worker or friend. Cases were more likely than controls to work outside the home (adjusted odds ratio (aOR) 1.18, 95% confidence interval (CI): 1.09-1.28) in industries and occupations related to accommodation and food services, retail sales, and construction. Cases were also more likely than controls to report contact with a non-household member with confirmed or suspected COVID-19 (aOR 1.16, 95% CI: 1.06-1.27).

conclusionsUnderstanding the settings and activities associated with a higher risk of SARS-CoV-2 infection is essential for informing prevention measures aimed at reducing the transmission of SARS-CoV-2 and other respiratory diseases. These findings emphasize the risk of community exposure to infected persons and the need for workplace precautions in preventing ongoing transmission.

Indexed as

COVID-19SARS-CoV-2Accommodation, OcularAdolescentAdultCase-Control StudiesColoradoHumans

Identifiers

PMID36862756
PMCPMC9980731
OpenAlexW4322758519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.